Literature DB >> 1691737

Differential regulation of HLA class I genes by interferon.

H Schmidt1, V Gekeler, H Haas, G Engler-Blum, I Steiert, H Probst, C A Müller.   

Abstract

Allele-specific differences in the regulation of HLA class I genes by type I interferon (IFN) were observed after transfection of eight HLA-B, -A, or -C genes into mouse L cells. HLA-B7 and -Bw64 gene expression was significantly more inducible by type I IFN than the genes coding for HLA-B27, HLA-B51, HLA-B38, HLA-B39, HLA-Cw3, and HLA-A2 antigens. Modification of the 5' end of HLA-B7 and HLA-B27 genes revealed the presence of enhancer sequences responding to IFN treatment in the 5' untranslated region of HLA-B7, but not of HLA-B27 and suggested further, independently acting enhancer elements downstream of the transcription initiation site. Comparison of 5' enhancer region sequences in correlation with type I IFN inducibility of the different HLA class I alleles indicated that the exchange of only two nucleotides in the interferon response sequence (IRS) or enhancer A region of HLA-B7 or -Bw64 could account for nonregulated promoters in all other HLA-A, -B, or -C alleles analyzed. Thus, type I IFN stimulation of HLA class I genes in mouse L cells appears to predominantly operate in most alleles by a mechanism targeted to enhancer sequences downstream of the gene's transcription initiation site.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691737     DOI: 10.1007/bf00204896

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  45 in total

1.  Interferon-induced transcription of a major histocompatibility class I gene accompanies binding of inducible nuclear factors to the interferon consensus sequence.

Authors:  Y Shirayoshi; P A Burke; E Appella; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

2.  Allelic variation in HLA-B and HLA-C sequences and the evolution of the HLA-B alleles.

Authors:  H Pohla; W Kuon; P Tabaczewski; C Doerner; E H Weiss
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

3.  Detailed analysis of the mouse H-2Kb promoter: enhancer-like sequences and their role in the regulation of class I gene expression.

Authors:  A Kimura; A Israël; O Le Bail; P Kourilsky
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

Review 4.  Molecular genetics of the human major histocompatibility complex.

Authors:  C Auffray; J L Strominger
Journal:  Adv Hum Genet       Date:  1986

Review 5.  Expression of class I transplantation antigens.

Authors:  H W Harris; T J Gill
Journal:  Transplantation       Date:  1986-08       Impact factor: 4.939

6.  Supercoil sequencing: a fast and simple method for sequencing plasmid DNA.

Authors:  E Y Chen; P H Seeburg
Journal:  DNA       Date:  1985-04

7.  Organization, sequence and expression of the HLA-B27 gene: a molecular approach to analyze HLA and disease associations.

Authors:  E H Weiss; W Kuon; C Dörner; M Lang; G Riethmüller
Journal:  Immunobiology       Date:  1985-12       Impact factor: 3.144

8.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

9.  Differential expression of the HLA-B7 and the HLA-A2 gene in transfected mouse L(tk-) cells after stimulation by mouse interferon.

Authors:  H Schmidt; T Forsthuber; H J Bühring; C A Müller
Journal:  Immunobiology       Date:  1987-01       Impact factor: 3.144

10.  Organization of the murine Mx gene and characterization of its interferon- and virus-inducible promoter.

Authors:  H Hug; M Costas; P Staeheli; M Aebi; C Weissmann
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

View more
  11 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

2.  Identification of cis sequences controlling efficient position-independent tissue-specific expression of human major histocompatibility complex class I genes in transgenic mice.

Authors:  J W Chamberlain; H A Vasavada; S Ganguly; S M Weissman
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

3.  Sequence polymorphism in the HLA-B promoter region.

Authors:  Z Yao; A Volgger; S Scholz; E D Albert
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

4.  HMT, encoded by H-2M3, is a neoclassical major histocompatibility class I antigen.

Authors:  C R Wang; K F Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

5.  In vivo induction of HLA molecules in patients with myeloproliferative syndrome during IFN alpha treatment.

Authors:  C A Müller; J Walz; R Zinser; H J Bühring; B Steinke; H Schmidt
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

6.  A novel downstream regulatory element of the mouse H-2Kb class I major histocompatibility gene.

Authors:  J Králová; P Jansa; J Forejt
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

7.  Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression.

Authors:  P J Keating; F V Cromme; M Duggan-Keen; P J Snijders; J M Walboomers; R D Hunter; P A Dyer; P L Stern
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

8.  Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.

Authors:  P Korkolopoulou; L Kaklamanis; F Pezzella; A L Harris; K C Gatter
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

Review 9.  Transcriptional and posttranscriptional regulations of the HLA-G gene.

Authors:  Erick C Castelli; Luciana C Veiga-Castelli; Layale Yaghi; Philippe Moreau; Eduardo A Donadi
Journal:  J Immunol Res       Date:  2014-03-13       Impact factor: 4.818

10.  MHC Class I Regulation: The Origin Perspective.

Authors:  Alicja Sznarkowska; Sara Mikac; Magdalena Pilch
Journal:  Cancers (Basel)       Date:  2020-05-04       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.